Disease States I Flashcards

1
Q

multi-system inflammatory disease of unknown etiology causing interstitial lung disease

A

sarcoidosis

MC lung, lymph node, eyes, skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

sarcoidosis causes which specific forms of pulmonary disease

A

pulmonary fibrosis

hilar lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

sarcoidosis pathophysiology

A

exaggerated immune response

develop non-caseating granulomatous disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

sarcoidosis epidemiology

A

MC in AA, women

AA disease tend to be more severe and unremitting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sarcoidosis clinical presentation

A

DOE, cough, chest pain

+/- fever, arthralgia, anorexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

systemic clinical manifestations of sarcoidosis

A

pulmonary
cutaneous
ocular
endocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pulmonary manifestations of sarcoidosis

A

hilar lymphadenopathy
interstitial lung dz
pulmonary HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cutaneous manifestations of sarcoidosis

A

erythema nodosum
skin plaques
panniculitis
violet rash on cheeks, nose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ocular manifestations of sarcoidosis

A

uveitis (can cause blindness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

endocrine manifestations of sarcoidosis

A

hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

erythema nodosum

A

skin manifestation of sarcoidosis

large red indurated nodule on extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diagnostic study used for sarcoidosis

A

CXR (shows the granules)

HRCT can be used to identify active alveoli’s or fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

lab eval of sarcoidosis

A

LFT’s
dihydroxy vitamin D levels
ACE levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sarcoidosis dx is confirmed by

A

BIOPSY of lung or lymph tissue

shows non caveating granulomas w/o fungus or TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

sarcoidosis stage I

A

hilar or mediastinal lymphadenopathy only

45-65% of pts @ diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

stage II sarcoidosis

A

lymphadenopathy and parenchymal disease

infiltrates

17
Q

stage III sarcoidosis

A

parenchymal disease (infiltrates only)

18
Q

sarcoidosis treatment

A

given to pts with pulmonary disease - oral corticosteroids over 6 months

NSAIDS for symptomatic relief

19
Q

sarcoidosis prognosis

A

2/3 remit w/in 10 yrs

important prognostic indicator is staging of dz on CXR

20
Q

etiologies of restrictive lung disease

A
Pleural (trapped lung, empyema)
Alveolar (edema, hemorrhage 
Interstitial (pulmonary fibrosis) 
Neuromuscular (myasthenia gravis, ALS)
Thoracic cage abnormalities (obesity)
21
Q

restrictive lung disease results when

A

poorly compliant chest wall

muscles expand chest wall too weak to create normal neg pressure

pulmonary tissue is poorly expandable

alveoli have poor ability to exchange O2

ventilation

22
Q

test used to diagnose lung disease

A

PFT’s

decreased total lung capacity

23
Q

restrictive lung disease PFT

A

Low lung volumes but normal FEV1/FVC ratio

24
Q

restrictive lung disease and diffusion capacity PFT

A

DECREASED DLCO = interstitial lung disease

NORMAL DLCO - neuromuscular, thoracic cage, pleural etiology)

25
interstitial lung disease
diffuse inflammation of the lung causing scaring and thickening of tissue between alveoli and capillaries RESTRICTIVE + DECREASED diffusion
26
patho of interstitial lung disease
injury to lungs (aspiration, smoke, dust) that doesn't heal properly patchy replacement of normal tissue with scar tissue and fibroblasts
27
end result of ILD
pulmonary fibrosis due to chronic inflammation
28
etiologies of ILD
long term exposure to toxins and pollutants connective tissue diseases medications and radiation
29
ILD presentation
varied dry cough > 6 months DOE progressing to DOR
30
diagnosis of ILD -- suspect then order
history (insidious onset, chronic symptoms) PE (systemic signs of pulmonary dz - clubbing) pulmonary function testing (restrictive and DLCO decreased) + lab testing, imaging, lavage/bx
31
lab testing ILD
arterial blood gas (hypoxemia) testing for specific etiology
32
imaging ILD
HRCT STUDY OF CHOICE shows fibrosis
33
bronco-alveolar lavage
lund tissue biopsy suggests severity, confirms diagnosis
34
management of ILD
treat underlying dz, pulmonology steroids/immunomodulators prompt tx of infection oxygen
35
pneumoconioses
collection of interstitial lung diseases caused by occupational exposure to inorganic mineral dust MC type is asbestosis
36
when to consider pneumoconiosis
history, exam, and diagnosis of ILD with occupational exposure risk
37
imaging and pneumoconiosis
involvement of upper lobes of lungs ** except asbestosis
38
Black lung
coal workers lung due to coal/dust exposure upper lobes show coal macule --> fibrosis
39
silicosis
upper lob opacity, EGGSHELL clarifications of lymphnodes ex. stonemason/sandblasting